PBM
Psyence Biomedical·NASDAQ
--
--(--)
--
--(--)
8.43 / 10
Outperform
PBM's fundamental assessment is excellent (8.4/10). Key strengths include a robust interest coverage ratio of 42.48%, favorable asset-to-market and profit-to-market value differentials, and a low cash-to-market deficit. Notable weaknesses are elevated days sales outstanding (313.91) and sub-par year-over-year revenue growth metrics. These factors collectively position the company in a high-risk, high-reward segment typical of micro-caps.
Analysis Checks(7/10)
Revenue-MV
Value-0.26
Score3/3
Weight19.14%
1M Return10.54%
Value-0.26
Score3/3
Weight19.14%
1M Return10.54%
Days sales outstanding
Value313.91
Score1/3
Weight-2.10%
1M Return-1.57%
Value313.91
Score1/3
Weight-2.10%
1M Return-1.57%
Net income-Revenue
Value-0.17
Score2/3
Weight15.27%
1M Return8.45%
Value-0.17
Score2/3
Weight15.27%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value42.48
Score2/3
Weight-1.53%
1M Return-1.11%
Value42.48
Score2/3
Weight-1.53%
1M Return-1.11%
Asset-MV
Value-0.50
Score3/3
Weight28.29%
1M Return13.15%
Value-0.50
Score3/3
Weight28.29%
1M Return13.15%
Total operating revenue (YoY growth rate %)
Value45.97
Score0/3
Weight-7.08%
1M Return-6.11%
Value45.97
Score0/3
Weight-7.08%
1M Return-6.11%
Profit-MV
Value0.46
Score3/3
Weight18.40%
1M Return9.28%
Value0.46
Score3/3
Weight18.40%
1M Return9.28%
PB-ROE
Value0.08
Score3/3
Weight20.69%
1M Return12.83%
Value0.08
Score3/3
Weight20.69%
1M Return12.83%
Operating revenue (YoY growth rate %)
Value64.40
Score0/3
Weight-6.09%
1M Return-5.06%
Value64.40
Score0/3
Weight-6.09%
1M Return-5.06%
Cash-MV
Value-0.07
Score2/3
Weight15.00%
1M Return8.41%
Value-0.07
Score2/3
Weight15.00%
1M Return8.41%
Revenue-MV
Value-0.26
Score3/3
Weight19.14%
1M Return10.54%
Value-0.26
Score3/3
Weight19.14%
1M Return10.54%
Total operating revenue (YoY growth rate %)
Value45.97
Score0/3
Weight-7.08%
1M Return-6.11%
Value45.97
Score0/3
Weight-7.08%
1M Return-6.11%
Days sales outstanding
Value313.91
Score1/3
Weight-2.10%
1M Return-1.57%
Value313.91
Score1/3
Weight-2.10%
1M Return-1.57%
Profit-MV
Value0.46
Score3/3
Weight18.40%
1M Return9.28%
Value0.46
Score3/3
Weight18.40%
1M Return9.28%
Net income-Revenue
Value-0.17
Score2/3
Weight15.27%
1M Return8.45%
Value-0.17
Score2/3
Weight15.27%
1M Return8.45%
PB-ROE
Value0.08
Score3/3
Weight20.69%
1M Return12.83%
Value0.08
Score3/3
Weight20.69%
1M Return12.83%
Interest coverage ratio (EBIT / Interest expense) (%)
Value42.48
Score2/3
Weight-1.53%
1M Return-1.11%
Value42.48
Score2/3
Weight-1.53%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value64.40
Score0/3
Weight-6.09%
1M Return-5.06%
Value64.40
Score0/3
Weight-6.09%
1M Return-5.06%
Asset-MV
Value-0.50
Score3/3
Weight28.29%
1M Return13.15%
Value-0.50
Score3/3
Weight28.29%
1M Return13.15%
Cash-MV
Value-0.07
Score2/3
Weight15.00%
1M Return8.41%
Value-0.07
Score2/3
Weight15.00%
1M Return8.41%
Is PBM undervalued or overvalued?
- PBM scores 8.43/10 on fundamentals and holds a Discounted valuation at present. Backed by its -21.44% ROE, 0.00% net margin, -0.81 P/E ratio, 0.27 P/B ratio, and 97.62% earnings growth, these metrics solidify its Outperform investment rating.
